Skip to main content
Top
Published in: Journal of Translational Medicine 1/2023

Open Access 01-12-2023 | Colorectal Cancer | Research

Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells

Authors: Muhong Wang, Chunyu Deng, Cheng Yang, Mingze Yan, Haibo Lu, Yan Zhang, Honghao Liu, Zhekuan Tong, Jiaao Ma, Jiaming Wang, Yan Zhang, Jiahao Wang, Yuhong Xuan, Haiyue Cheng, Kai Zhao, Jiaqi Zhang, Cuicui Chai, Mingzhe Li, Zhiwei Yu

Published in: Journal of Translational Medicine | Issue 1/2023

Login to get access

Abstract

The occurrence and progression of tumors can be established through a complex interplay among tumor cells undergoing epithelial-mesenchymal transition (EMT), invasive factors and immune cells. In this study, we employed single-cell RNA sequencing (scRNA-seq) and spatially resolved transcriptomics (ST) to evaluate the pseudotime trajectory and spatial interactive relationship between EMT-invasive malignant tumors and immune cells in primary colorectal cancer (CRC) tissues at different stages (stage I/II and stage III with tumor deposit). Our research characterized the spatiotemporal relationship among different invasive tumor programs by constructing pseudotime endpoint-EMT-invasion tumor programs (EMTPs) located at the edge of ST, utilizing evolution trajectory analysis integrated with EMT-invasion genes. Strikingly, the invasive and expansive process of tumors undergoes remarkable spatial reprogramming of regulatory and immunosuppressive cells, such as myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), regulatory T cells (Treg), and exhausted T cells (Tex). These EMTP-adjacent cell are linked to EMT-related invasion genes, especially the C-X-C motif ligand 1 (CXCL1) and CXCL8 genes that are important for CRC prognosis. Interestingly, the EMTPs in stage I mainly produce an inflammatory margin invasive niche, while the EMTPs in stage III tissues likely produce a hypoxic pre-invasive niche. Our data demonstrate the crucial role of regulatory and immunosuppressive cells in tumor formation and progression of CRC. This study provides a framework to delineate the spatiotemporal invasive niche in CRC samples.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49.CrossRef Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49.CrossRef
3.
go back to reference Ohnmacht AJ, et al. The oncology biomarker discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. Nat Commun. 2023;14:5391.PubMedPubMedCentralCrossRef Ohnmacht AJ, et al. The oncology biomarker discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. Nat Commun. 2023;14:5391.PubMedPubMedCentralCrossRef
4.
go back to reference Fattahi M, et al. microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance. Int J Biol Macromol. 2023;250:125863.PubMedCrossRef Fattahi M, et al. microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance. Int J Biol Macromol. 2023;250:125863.PubMedCrossRef
5.
go back to reference Shirvani H, et al. MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer. Cell Signal. 2023;101:110504.PubMedCrossRef Shirvani H, et al. MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer. Cell Signal. 2023;101:110504.PubMedCrossRef
6.
go back to reference Bahari Khasraghi L, et al. MicroRNA-206 in human cancer: Mechanistic and clinical perspectives. Cell Signal. 2023;101:110525.PubMedCrossRef Bahari Khasraghi L, et al. MicroRNA-206 in human cancer: Mechanistic and clinical perspectives. Cell Signal. 2023;101:110525.PubMedCrossRef
7.
go back to reference Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162:715–730713.PubMedCrossRef Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162:715–730713.PubMedCrossRef
8.
go back to reference Liu Y, Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016;30:668–81.PubMedCrossRef Liu Y, Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016;30:668–81.PubMedCrossRef
10.
go back to reference Liu Y, Cao X. Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl). 2016;94:509–22.PubMedCrossRef Liu Y, Cao X. Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl). 2016;94:509–22.PubMedCrossRef
14.
go back to reference Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.PubMedPubMedCentralCrossRef Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.PubMedPubMedCentralCrossRef
15.
go back to reference Gonzalez-Silva L, Quevedo L, Varela I. Tumor functional heterogeneity unraveled by scRNA-seq technologies. Trends Cancer. 2021;7:265.PubMedCrossRef Gonzalez-Silva L, Quevedo L, Varela I. Tumor functional heterogeneity unraveled by scRNA-seq technologies. Trends Cancer. 2021;7:265.PubMedCrossRef
16.
go back to reference Liu Y, et al. Immune phenotypic linkage between colorectal cancer and liver metastasis. Cancer Cell. 2022;40:424-437 e425.PubMedCrossRef Liu Y, et al. Immune phenotypic linkage between colorectal cancer and liver metastasis. Cancer Cell. 2022;40:424-437 e425.PubMedCrossRef
18.
go back to reference Asp M, Bergenstrahle J, Lundeberg J. Spatially resolved transcriptomes-next generation tools for tissue exploration. Bio Essays News Rev Mol Cell Develop Biol. 2020;42:e1900221.CrossRef Asp M, Bergenstrahle J, Lundeberg J. Spatially resolved transcriptomes-next generation tools for tissue exploration. Bio Essays News Rev Mol Cell Develop Biol. 2020;42:e1900221.CrossRef
19.
go back to reference Ahmed R, et al. Spatial mapping of cancer tissues by OMICS technologies. Biochim Biophys Acta Rev Cancer. 2022;1877:188663.PubMedCrossRef Ahmed R, et al. Spatial mapping of cancer tissues by OMICS technologies. Biochim Biophys Acta Rev Cancer. 2022;1877:188663.PubMedCrossRef
20.
go back to reference Stahl PL, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353:78–82.PubMedCrossRef Stahl PL, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353:78–82.PubMedCrossRef
22.
23.
go back to reference Zhang X, et al. Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47:D721–8.PubMedCrossRef Zhang X, et al. Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47:D721–8.PubMedCrossRef
25.
go back to reference Zhang Y, et al. scTPA: a web tool for single-cell transcriptome analysis of pathway activation signatures. Bioinformatics. 2020;36:4217–9.PubMedCrossRef Zhang Y, et al. scTPA: a web tool for single-cell transcriptome analysis of pathway activation signatures. Bioinformatics. 2020;36:4217–9.PubMedCrossRef
27.
go back to reference Qi M, Li W, Tsang IW, Yijun S. Principal graph and structure learning based on reversed graph embedding. IEEE Trans Pattern Anal Mach Intell. 2017;39:2227–41.CrossRef Qi M, Li W, Tsang IW, Yijun S. Principal graph and structure learning based on reversed graph embedding. IEEE Trans Pattern Anal Mach Intell. 2017;39:2227–41.CrossRef
30.
go back to reference Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17:159–62.PubMedCrossRef Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17:159–62.PubMedCrossRef
31.
go back to reference Li T, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Can Res. 2017;77:e108–10.CrossRef Li T, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Can Res. 2017;77:e108–10.CrossRef
32.
go back to reference Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/beta-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13.PubMedPubMedCentralCrossRef Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/beta-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13.PubMedPubMedCentralCrossRef
33.
go back to reference Venkateswaran N, Conacci-Sorrell M. MYC leads the way small. GTPases. 2020;11:86–94.CrossRef Venkateswaran N, Conacci-Sorrell M. MYC leads the way small. GTPases. 2020;11:86–94.CrossRef
34.
go back to reference Xiang H, et al. Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res. 2020;8:436–50.PubMedCrossRef Xiang H, et al. Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res. 2020;8:436–50.PubMedCrossRef
35.
go back to reference Zhang Y, et al. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases. Cancer Lett. 2020;470:84–94.PubMedCrossRef Zhang Y, et al. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases. Cancer Lett. 2020;470:84–94.PubMedCrossRef
36.
go back to reference Taki M, et al. Tumor immune microenvironment during epithelial-mesenchymal transition. Clin Cancer Res. 2021;27:4669–79.PubMedCrossRef Taki M, et al. Tumor immune microenvironment during epithelial-mesenchymal transition. Clin Cancer Res. 2021;27:4669–79.PubMedCrossRef
37.
go back to reference Cai J, Cui Y, Yang J, Wang S. Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells. Biochim Biophys Acta Rev Cancer. 2021;1876:188564.PubMedCrossRef Cai J, Cui Y, Yang J, Wang S. Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells. Biochim Biophys Acta Rev Cancer. 2021;1876:188564.PubMedCrossRef
38.
go back to reference Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updat. 2020;53:100715.PubMedCrossRef Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updat. 2020;53:100715.PubMedCrossRef
40.
44.
go back to reference Azenshtein E, et al. The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett. 2005;217:73–86.PubMedCrossRef Azenshtein E, et al. The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett. 2005;217:73–86.PubMedCrossRef
45.
go back to reference Benci JL, et al. Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade. Cell. 2019;178:933-948 e914.PubMedPubMedCentralCrossRef Benci JL, et al. Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade. Cell. 2019;178:933-948 e914.PubMedPubMedCentralCrossRef
46.
go back to reference Miller BC, et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20:326–36.PubMedPubMedCentralCrossRef Miller BC, et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20:326–36.PubMedPubMedCentralCrossRef
49.
50.
go back to reference Bouchard G, et al. Multiomics analysis of spatially distinct stromal cells reveals tumor-induced O-glycosylation of the CDK4-pRB axis in fibroblasts at the invasive tumor edge. Can Res. 2022;82:648–64.CrossRef Bouchard G, et al. Multiomics analysis of spatially distinct stromal cells reveals tumor-induced O-glycosylation of the CDK4-pRB axis in fibroblasts at the invasive tumor edge. Can Res. 2022;82:648–64.CrossRef
51.
go back to reference Wu Y, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12:134–53.PubMedCrossRef Wu Y, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12:134–53.PubMedCrossRef
52.
go back to reference Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol. 2016;16:35–50.PubMedCrossRef Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol. 2016;16:35–50.PubMedCrossRef
55.
go back to reference Zhuo C, Ruan Q, Zhao X, Shen Y, Lin R. CXCL1 promotes colon cancer progression through activation of NF-kappaB/P300 signaling pathway. Biol Direct. 2022;17:34.PubMedPubMedCentralCrossRef Zhuo C, Ruan Q, Zhao X, Shen Y, Lin R. CXCL1 promotes colon cancer progression through activation of NF-kappaB/P300 signaling pathway. Biol Direct. 2022;17:34.PubMedPubMedCentralCrossRef
56.
go back to reference Tang H, et al. HSP90/IKK-rich small extracellular vesicles activate pro-angiogenic melanoma-associated fibroblasts via the NF-kappaB/CXCL1 axis. Cancer Sci. 2022;113:1168–81.PubMedPubMedCentralCrossRef Tang H, et al. HSP90/IKK-rich small extracellular vesicles activate pro-angiogenic melanoma-associated fibroblasts via the NF-kappaB/CXCL1 axis. Cancer Sci. 2022;113:1168–81.PubMedPubMedCentralCrossRef
57.
go back to reference Bodogai M, et al. Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells. Can Res. 2015;75:3456–65.CrossRef Bodogai M, et al. Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells. Can Res. 2015;75:3456–65.CrossRef
58.
go back to reference Tang F, et al. Targeting myeloid-derived suppressor cells for premetastatic niche disruption after tumor resection. Ann Surg Oncol. 2021;28:4030–48.PubMedCrossRef Tang F, et al. Targeting myeloid-derived suppressor cells for premetastatic niche disruption after tumor resection. Ann Surg Oncol. 2021;28:4030–48.PubMedCrossRef
61.
go back to reference Schott AF, et al. Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-negative metastatic breast cancer. Clin Cancer Res. 2017;23:5358–65.PubMedPubMedCentralCrossRef Schott AF, et al. Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-negative metastatic breast cancer. Clin Cancer Res. 2017;23:5358–65.PubMedPubMedCentralCrossRef
62.
go back to reference Goldstein LJ, et al. A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida). Breast Cancer Res Treat. 2021;190:265–75.PubMedPubMedCentralCrossRef Goldstein LJ, et al. A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida). Breast Cancer Res Treat. 2021;190:265–75.PubMedPubMedCentralCrossRef
64.
go back to reference Yang J, et al. Targeted deletion of CXCR2 in myeloid cells alters the tumor immune environment to improve antitumor immunity. Cancer Immunol Res. 2021;9:200–13.PubMedCrossRef Yang J, et al. Targeted deletion of CXCR2 in myeloid cells alters the tumor immune environment to improve antitumor immunity. Cancer Immunol Res. 2021;9:200–13.PubMedCrossRef
65.
go back to reference Ning Y, et al. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2012;11:1353–64.PubMedCrossRef Ning Y, et al. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2012;11:1353–64.PubMedCrossRef
66.
go back to reference Zhou Z, et al. Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy. Acta Pharm Sin B. 2022;12:4204–23.PubMedPubMedCentralCrossRef Zhou Z, et al. Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy. Acta Pharm Sin B. 2022;12:4204–23.PubMedPubMedCentralCrossRef
67.
go back to reference Miano JM. Role of serum response factor in the pathogenesis of disease. Lab Invest. 2010;90:1274–84.PubMedCrossRef Miano JM. Role of serum response factor in the pathogenesis of disease. Lab Invest. 2010;90:1274–84.PubMedCrossRef
68.
go back to reference Lin C, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019;68:1764–73.PubMedCrossRef Lin C, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019;68:1764–73.PubMedCrossRef
69.
go back to reference Wang N, et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappaB/SOX4 signaling. Cell Death Dis. 2018;9:880.PubMedPubMedCentralCrossRef Wang N, et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappaB/SOX4 signaling. Cell Death Dis. 2018;9:880.PubMedPubMedCentralCrossRef
71.
go back to reference Nie G, et al. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin. Int Immunopharmacol. 2021;95:107153.PubMedCrossRef Nie G, et al. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin. Int Immunopharmacol. 2021;95:107153.PubMedCrossRef
72.
go back to reference Yang C, et al. CXCL1 stimulates migration and invasion in ER-negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis. Int J Oncol. 2019;55:684–96.PubMedPubMedCentral Yang C, et al. CXCL1 stimulates migration and invasion in ER-negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis. Int J Oncol. 2019;55:684–96.PubMedPubMedCentral
73.
go back to reference Qiao J, Liu Z, Yang C, Gu L, Deng D. SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-CXCR4-dependent manner. Oncotarget. 2016;7:46088–99.PubMedPubMedCentralCrossRef Qiao J, Liu Z, Yang C, Gu L, Deng D. SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-CXCR4-dependent manner. Oncotarget. 2016;7:46088–99.PubMedPubMedCentralCrossRef
74.
go back to reference 2011. Correction to: overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol. 22:2537. 2011. Correction to: overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol. 22:2537.
75.
go back to reference Lee HO, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52:594–603.PubMedCrossRef Lee HO, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52:594–603.PubMedCrossRef
76.
Metadata
Title
Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells
Authors
Muhong Wang
Chunyu Deng
Cheng Yang
Mingze Yan
Haibo Lu
Yan Zhang
Honghao Liu
Zhekuan Tong
Jiaao Ma
Jiaming Wang
Yan Zhang
Jiahao Wang
Yuhong Xuan
Haiyue Cheng
Kai Zhao
Jiaqi Zhang
Cuicui Chai
Mingzhe Li
Zhiwei Yu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2023
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-023-04600-x

Other articles of this Issue 1/2023

Journal of Translational Medicine 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.